Global Drug Discovery Technologies Market (2022-2027) by Technology, End-User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Drug Discovery Technologies Market (2022-2027) by Technology, End-User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis


The Global Drug Discovery Technologies Market is estimated to be USD 60.88 Bn in 2022 and is expected to reach USD 100.75 Bn by 2027, growing at a CAGR of 10.6%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Drug Discovery Technologies Market is segmented based on Technology, End-User, and Geography.

  • By Technology, the market is classified into Bioanalytical Instruments, Biochips, Bioinformatics, CombinatorialChemistry, Genomics, High Throughput Screening, Nanotechnology, Pharmacogenomics, and RNAI.
  • By End-User, the market is classified into Biopharmaceutical Companies, Biotech Companies, Pharmaceutical Companies, and Research Institutes.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.
Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Affymetrix Inc, Agilent, Albany Molecular Research, Inc., Arqule, Inc., AstraZeneca Plc, Bio-Rad Laboratories, Bayer Healthcare Ag, Caliper Life Sciences, etc.

Countries Studied
  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Drug Discovery Technologies Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. Infogence Global Research analyses the Global Drug Discovery Technologies Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report?
  • The report offers a comprehensive evaluation of the Global Drug Discovery Technologies Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence's Proprietary competitive positioning tool.
Report Highlights:
  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Incidences of Diseases
4.1.2 Increased Demand for Drug and Biologics Due to Benefits, Such as Highly Effective and Potent Action, and Fewer Side Effects
4.1.3 Increasing R&D Expenditure and Investment for Development of Novel Drug Molecules
4.2 Restraints
4.2.1 High Initial Setup Cost for Drug Discovery and Development
4.2.2 Need for Long Duration of Drug Discovery Process
4.3 Opportunities
4.3.1 Advances in the Fields of Biotechnology, Molecular Biology, Nanotechnology, and Genomics
4.3.2 Patent Expiries of Several Drugs
4.4 Challenges
4.4.1 Presence of Stringent Regulatory Environment
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Drug Discovery Technologies Market, By Technology
6.1 Introduction
6.2 Bioanalytical Instruments
6.3 Biochips
6.4 Bioinformatics
6.5 Combinatorial Chemistry
6.6 Genomics
6.7 High Throughput Screening
6.8 Nanotechnology
6.9 Pharmacogenomics
6.10 RNAI
7 Global Drug Discovery Technologies Market, By End-User
7.1 Introduction
7.2 Biopharmaceutical Companies
7.3 Biotech Companies
7.4 Pharmaceutical Companies
7.5 Research Institutes
8 Americas’ Drug Discovery Technologies Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Drug Discovery Technologies Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Drug Discovery Technologies Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Drug Discovery Technologies Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 IGR Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 Affymetrix Inc
13.3 Agilent
13.4 Albany Molecular Research, Inc.
13.5 Arqule, Inc.
13.6 AstraZeneca Plc
13.7 Bio-Rad Laboratories
13.8 Bayer Healthcare Ag
13.9 Caliper Life Sciences
13.10 Celera Corp
13.11 Charles River Laboratories International
13.12 Evotec Ag
13.13 GE Healthcare Ltd.
13.14 Genesis Therapeutics
13.15 GlaxoSmithKline Plc
13.16 Gyros AbIncyte Corp
13.17 Hoffmann-La Roche Ltd.
13.18 Luminex Corp.
13.19 Merck & Co. Inc.
13.20 Novartis Ag
13.21 Pfizer, Inc.
13.22 Thermo Fisher Scientific Inc
14 Appendix
14.1 Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings